Rossby Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Rossby Financial's XBI Position: Q1 2026 in Review
Rossby Financial increased its State Street SPDR S&P Biotech ETF (XBI) stake by 150% in Q1 2026, buying an estimated $18.7K and bringing the position to 250 shares worth $32.1K. The position accounts for 0.01% of the portfolio, ranked #874.
Rossby Financial first reported a position in XBI in Q2 2025 and has held it in 4 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Rossby Financial held 250 shares of State Street SPDR S&P Biotech ETF worth $32.1K as of Q1 2026.
- Rossby Financial bought 150 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $18.7K.
- State Street SPDR S&P Biotech ETF made up 0.01% of Rossby Financial's portfolio in Q1 2026, its #874 holding.
- Rossby Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and has held it in 4 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Rossby Financial's 13F filing for Q1 2026, filed 11 May 2026.